Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2008 (2008), Article ID 594868, 10 pages
http://dx.doi.org/10.1155/2008/594868
Review Article

Preclinical Evidence for the Benefits of Penile Rehabilitation Therapy following Nerve-Sparing Radical Prostatectomy

Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium

Received 30 April 2008; Accepted 7 May 2008

Academic Editor: Edward Kim

Copyright © 2008 M. Albersen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Heidenreich, G. Aus, M. Bolla et al., “EAU guidelines on prostate cancer,” European Urology, vol. 53, no. 1, pp. 68–80, 2008. View at Publisher · View at Google Scholar · View at PubMed
  2. P. C. Walsh and P. J. Donker, “Impotence following radical prostatectomy: insight into etiology and prevention,” Journal of Urology, vol. 128, no. 3, pp. 492–497, 1982. View at Google Scholar
  3. P. C. Walsh, “Anatomic radical retropubic prostatectomy,” in Campbell's Urology, P. C. Walsh, A. B. Retik, E. D. Vaughan, and A. J. Wein, Eds., pp. 2565–2588, WB Saunders, Philadelphia, Pa, USA, 7th edition, 1997. View at Google Scholar
  4. F. Van Der Aa, S. Joniau, D. De Ridder, and H. Van Poppel, “Potency after unilateral nerve sparing surgery: a report on functional and oncological results of unilateral nerve sparing surgery,” Prostate Cancer and Prostatic Diseases, vol. 6, no. 1, pp. 61–65, 2003. View at Publisher · View at Google Scholar · View at PubMed
  5. S. D. Kundu, K. A. Roehl, S. E. Eggener, J. A. V. Antenor, M. Han, and W. J. Catalona, “Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies,” Journal of Urology, vol. 172, no. 6, part 1, pp. 2227–2231, 2004. View at Publisher · View at Google Scholar
  6. J. W. Saranchuk, M. W. Kattan, E. Elkin, A. K. Touijer, P. T. Scardino, and J. A. Eastham, “Achieving optimal outcomes after radical prostatectomy,” Journal of Clinical Oncology, vol. 23, no. 18, pp. 4146–4151, 2005. View at Publisher · View at Google Scholar · View at PubMed
  7. J. L. Stanford, Z. Feng, A. S. Hamilton et al., “Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the prostate cancer outcomes study,” Journal of the American Medical Association, vol. 283, no. 3, pp. 354–360, 2000. View at Publisher · View at Google Scholar
  8. J. Noldus, U. Michl, M. Graefen, A. Haese, P. Hammerer, and H. Huland, “Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy,” European Urology, vol. 42, no. 2, pp. 118–124, 2002. View at Publisher · View at Google Scholar
  9. M. Graefen, J. Walz, and H. Huland, “Open retropubic nerve-sparing radical prostatectomy,” European Urology, vol. 49, no. 1, pp. 38–48, 2006. View at Publisher · View at Google Scholar · View at PubMed
  10. P. C. Walsh, P. Marschke, D. Ricker, and A. L. Burnett, “Patient-reported urinary continence and sexual function after anatomic radical prostatectomy,” Urology, vol. 55, no. 1, pp. 58–61, 2000. View at Publisher · View at Google Scholar
  11. A. L. Burnett, I. Thompson, and B. Thrasher, “Erectile function outcome reporting after clinically localized prostate cancer treatment,” Journal of Sexual Medicine, vol. 4, supplement 1, p. 98, 2007, abstract 104. View at Google Scholar
  12. M. Albersen, S. Joniau, H. Claes, and H. Van Poppel, “The use of the IIEF-5 questionnaire for evaluation of erectile dysfunction following nerve-sparing radical prostatectomy,” Journal of Sexual Medicine, vol. 4, supplement 2, pp. 6–57, 2006. View at Google Scholar
  13. F. Montorsi, G. Guazzoni, L. F. Strambi et al., “Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial,” Journal of Urology, vol. 158, no. 4, pp. 1408–1410, 1997. View at Publisher · View at Google Scholar
  14. H. Padma-Nathan, “PDE-5 inhibitor therapy for erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy,” Reviews in Urology, vol. 7, supplement 2, pp. S33–S38, 2005. View at Google Scholar
  15. H. Padma-Nathan, A. McCullough, F. Guiliano et al., “Postoperative nightly administration of sildenafil citrate significantly improves normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy,” Journal of Urology, vol. 169, supplement 4, p. 375, 2003. View at Google Scholar
  16. P. T. Scardino and E. D. Kim, “Rationale for and results of nerve grafting during radical prostatectomy,” Urology, vol. 57, no. 6, pp. 1016–1019, 2001. View at Publisher · View at Google Scholar
  17. F. May, K. Matiasek, M. Vroemen et al., “GDNF-transduced Schwann cell grafts enhance regeneration of erectile nerves,” European Urology. In press. View at Publisher · View at Google Scholar · View at PubMed
  18. C. Eichelberg, A. Erbersdobler, U. Michl et al., “Nerve distribution along the prostatic capsule,” European Urology, vol. 51, no. 1, pp. 105–111, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. S. Kaul, A. Bhandari, A. Hemal, A. Savera, A. Shrivastava, and M. Menon, “Robotic radical prostatectomy with preservation of the prostatic fascia: a feasibility study,” Urology, vol. 66, no. 6, pp. 1261–1265, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. A. J. Costello, M. Brooks, and O. J. Cole, “Anatomical studies of the neurovascular bundle and cavernosal nerves,” BJU International, vol. 94, no. 7, pp. 1071–1076, 2004. View at Publisher · View at Google Scholar · View at PubMed
  21. H. Claes, W. van de Voorde, S. Vandeginste et al., “A histopathological study of deep dorsal penile vein in venogenic impotence,” Acta Urologica Belgica, vol. 62, no. 4, pp. 61–67, 1994. View at Google Scholar
  22. H. Claes, B. Bijnens, and L. Baert, “The hemodynamic influence of the ischiocavernosus muscles on erectile function,” Journal of Urology, vol. 156, no. 3, pp. 986–990, 1996. View at Publisher · View at Google Scholar
  23. A. R. McCullough, “Rehabilitation of erectile function following radical prostatectomy,” Asian Journal of Andrology, vol. 10, no. 1, pp. 61–74, 2008. View at Publisher · View at Google Scholar · View at PubMed
  24. T. F. Lue, “Erectile dysfunction,” The New England Journal of Medicine, vol. 342, no. 24, pp. 1802–1813, 2000. View at Publisher · View at Google Scholar
  25. K. M. Azadzoi, J. Vlachiotis, M. Pontari, and M. B. Siroky, “Hemodynamics of penile erection—III: measurement of deep intracavernosal and subtunical blood flow and oxygen tension,” Journal of Urology, vol. 153, no. 2, pp. 521–526, 1995. View at Publisher · View at Google Scholar · View at PubMed
  26. C. Fischer, J. Gross, and J. Zuch, “Cycle of penile erections synchronous with dreaming (REM) sleep: preliminary report,” Archives of General Psychiatry, vol. 12, pp. 29–45, 1965. View at Google Scholar
  27. A. Bannowsky, H. Schulze, C. van der Horst, C. Seif, P. M. Braun, and K.-P. Jünemann, “Nocturnal tumescence: a parameter for postoperative erectile integrity after nerve sparing radical prostatectomy,” Journal of Urology, vol. 175, no. 6, pp. 2214–2217, 2006. View at Publisher · View at Google Scholar · View at PubMed
  28. S. Leungwattanakij, T. J. Bivalacqua, M. F. Usta et al., “Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum,” Journal of Andrology, vol. 24, no. 2, pp. 239–245, 2003. View at Google Scholar
  29. M. Chiappe-Gutierrez, E. Kitzmueller, O. Labudova et al., “mRNA levels of the hypoxia inducible factor (HIF-1) and DNA repair genes in perinatal asphyxia of the rat,” Life Sciences, vol. 63, no. 13, pp. 1157–1167, 1998. View at Publisher · View at Google Scholar
  30. N. Kim, K. M. Azadzoi, I. Goldstein, and I. Saenz de Tejada, “A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle,” Journal of Clinical Investigation, vol. 88, no. 1, pp. 112–118, 1991. View at Publisher · View at Google Scholar · View at PubMed
  31. J. G. De Mey and P. M. Vanhoutte, “Anoxia and endothelium-dependent reactivity of the canine femoral artery,” Journal of Physiology, vol. 335, pp. 65–74, 1983. View at Google Scholar
  32. R. A. Johns, J. M. Linden, and M. J. Peach, “Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia,” Circulation Research, vol. 65, no. 6, pp. 1508–1515, 1989. View at Google Scholar
  33. T. Murata, H. Yamawaki, M. Hori, K. Sato, H. Ozaki, and H. Karaki, “Hypoxia impairs endothelium-dependent relaxation in organ cultured pulmonary artery,” European Journal of Pharmacology, vol. 421, no. 1, pp. 45–53, 2001. View at Publisher · View at Google Scholar
  34. P. W. Shaul, M. A. Farrar, and T. M. Zellers, “Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries,” American Journal of Physiology, vol. 262, no. 2, part 2, pp. H355–H364, 1992. View at Google Scholar
  35. N. Kim, Y. Vardi, H. Padma-Nathan, J. Daley, I. Goldstein, and I. Saenz de Tejada, “Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection,” Journal of Clinical Investigation, vol. 91, no. 2, pp. 437–442, 1993. View at Publisher · View at Google Scholar · View at PubMed
  36. M. C. Fraiman, H. Lepor, and A. R. McCullough, “Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy,” Molecular Urology, vol. 3, no. 2, pp. 109–115, 1999. View at Google Scholar
  37. M. D. Munding, H. B. Wessells, and B. L. Dalkin, “Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy,” Urology, vol. 58, no. 4, pp. 567–569, 2001. View at Publisher · View at Google Scholar
  38. M. Savoie, S. S. Kim, and M. S. Soloway, “A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer,” Journal of Urology, vol. 169, no. 4, pp. 1462–1464, 2003. View at Publisher · View at Google Scholar · View at PubMed
  39. P. Gontero, M. Galzerano, R. Bartoletti et al., “New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function,” Journal of Urology, vol. 178, no. 2, pp. 602–607, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. H. M. User, J. H. Hairston, D. J. Zelner, K. E. McKenna, and K. T. McVary, “Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction,” Journal of Urology, vol. 169, no. 3, pp. 1175–1179, 2003. View at Publisher · View at Google Scholar · View at PubMed
  41. L. T. Klein, M. I. Miller, R. Buttyan et al., “Apoptosis in the rat penis after penile denervation,” Journal of Urology, vol. 158, no. 2, pp. 626–630, 1997. View at Publisher · View at Google Scholar
  42. J. P. Mulhall, “Penile length changes after radical prostatectomy,” BJU International, vol. 96, no. 4, pp. 472–474, 2005. View at Publisher · View at Google Scholar · View at PubMed
  43. R. Levi-Montalcini, “The nerve growth factor: its role in growth, differentiation and function of the sympathetic adrenergic neuron,” Progress in Brain Research, vol. 45, pp. 235–258, 1976. View at Google Scholar
  44. S. Zhou, L. S. Chen, Y. Miyauchi et al., “Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs,” Circulation Research, vol. 95, no. 1, pp. 76–83, 2004. View at Publisher · View at Google Scholar · View at PubMed
  45. F. Montorsi, A. Briganti, A. Salonia, P. Rigatti, and A. L. Burnett, “Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy,” European Urology, vol. 45, no. 2, pp. 123–133, 2004. View at Publisher · View at Google Scholar
  46. J. P. Mulhall and R. J. Graydon, “The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy,” International Journal of Impotence Research, vol. 8, no. 2, pp. 91–94, 1996. View at Google Scholar
  47. E. D. Kim, D. Blackburn, and K. T. McVary, “Post-radical prostatectomy penile blood flow: assessment with color flow Doppler ultrasound,” Journal of Urology, vol. 152, no. 6, pp. 2276–2279, 1994. View at Google Scholar
  48. C. A. Podlasek, D. J. Zelner, J. D. Harris et al., “Altered sonic hedgehog signaling is associated with morphological abnormalities in the penis of the BB/WOR diabetic rat,” Biology of Reproduction, vol. 69, no. 3, pp. 816–827, 2003. View at Publisher · View at Google Scholar · View at PubMed
  49. C. A. Podlasek, D. J. Zelner, H. B. Jiang et al., “Sonic hedgehog cascade is required for penile postnatal morphogenesis, differentiation, and adult homeostasis,” Biology of Reproduction, vol. 68, no. 2, pp. 423–438, 2003. View at Publisher · View at Google Scholar
  50. C. A. Podlasek, C. L. Meroz, H. Korolis, Y. Tang, K. E. McKenna, and K. T. McVary, “Sonic hedgehog, the penis and erectile dysfunction: a review of sonic hedgehog signaling in the penis,” Current Pharmaceutical Design, vol. 11, no. 31, pp. 4011–4027, 2005. View at Publisher · View at Google Scholar
  51. C. Bond, Y. Tang, and C. A. Podlasek, “Neural influences on sonic hedgehog and apoptosis in the rat penis,” Biology of Reproduction, vol. 78, no. 5, pp. 947–956, 2008. View at Publisher · View at Google Scholar · View at PubMed
  52. S. Granchi, G. B. Vannelli, L. Vignozzi et al., “Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells,” Molecular Human Reproduction, vol. 8, no. 12, pp. 1053–1064, 2002. View at Publisher · View at Google Scholar
  53. W.-L. Hu, L.-Q. Hu, J. Song et al., “Fibrosis of corpus cavernosum in animals following cavernous nerve ablation,” Asian Journal of Andrology, vol. 6, no. 2, pp. 111–116, 2004. View at Google Scholar
  54. W.-L. Hu, L.-Q. Hu, S.-W. Li, X.-M. Zheng, and B.-C. Tian, “Expression of transforming growth factor-β1 in penile tissue from rats with bilateral cavernosal nerve ablation,” BJU International, vol. 94, no. 3, pp. 424–428, 2004. View at Publisher · View at Google Scholar · View at PubMed
  55. R. B. Moreland, A. Traish, M. A. McMillin, B. Smith, I. Goldstein, and I. Saenz de Tejada, “PGE1 suppresses the induction of collagen synthesis by transforming growth factor-β1 in human corpus cavernosum smooth muscle,” Journal of Urology, vol. 153, no. 3, pp. 826–834, 1995. View at Publisher · View at Google Scholar
  56. R. B. Moreland, “Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence,” International Journal of Impotence Research, vol. 10, no. 2, pp. 113–120, 1998. View at Publisher · View at Google Scholar
  57. J. T. Daley, M. L. Brown, M. T. Watkins et al., “Prostanoid production in rabbit corpus cavernosum—I: regulation by oxygen tension,” Journal of Urology, vol. 155, no. 4, pp. 1482–1487, 1996. View at Publisher · View at Google Scholar
  58. J. T. Daley, M. T. Watkins, M. L. Brown, V. Martinez, P. Cuevas, and I. Saenz de Tejada, “Prostanoid production in rabbit corpus cavernosum—II: inhibition by oxidative stress,” Journal of Urology, vol. 156, no. 3, pp. 1169–1173, 1996. View at Publisher · View at Google Scholar
  59. A. Nehra, M. Gettman , M. Nugent et al., “Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo,” Journal of Urology, vol. 162, no. 3, pp. 910–915, 1999. View at Google Scholar
  60. R. B. Moreland, S. Gupta, I. Goldstein, and A. Traish, “Cyclic AMP modulates TGF-β1-induced fibrillar collagen synthesis in cultured human corpus cavernosum smooth muscle cells,” International Journal of Impotence Research, vol. 10, no. 3, pp. 159–163, 1998. View at Publisher · View at Google Scholar
  61. N. N. Kim, Y. Huang, R. B. Moreland, S. S. Kwak, I. Goldstein, and A. Traish, “Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells,” Molecular Cell Biology Research Communications, vol. 4, no. 1, pp. 10–14, 2000. View at Publisher · View at Google Scholar · View at PubMed
  62. I. Kovanecz, A. Rambhatla, M. Ferrini et al., “Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats,” International Journal of Impotence Research, vol. 20, no. 2, pp. 202–212, 2008. View at Publisher · View at Google Scholar · View at PubMed
  63. M. G. Ferrini, H. H. Davila, I. Kovanecz, S. P. Sanchez, N. F. Gonzalez-Cadavid, and J. Rajfer, “Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat,” Urology, vol. 68, no. 2, pp. 429–435, 2006. View at Publisher · View at Google Scholar · View at PubMed
  64. I. Kovanecz, A. Rambhatla, M. G. Ferrini et al., “Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection,” BJU International, vol. 101, no. 2, pp. 203–210, 2008. View at Publisher · View at Google Scholar · View at PubMed
  65. L. Vignozzi, S. Filippi, A. Morelli et al., “Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat,” Journal of Sexual Medicine, vol. 3, no. 3, pp. 419–431, 2006. View at Publisher · View at Google Scholar · View at PubMed
  66. L. Vignozzi, A. Morelli, S. Filippi et al., “Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat,” International Journal of Impotence Research, vol. 20, no. 1, pp. 60–67, 2008. View at Publisher · View at Google Scholar · View at PubMed
  67. A. Rambhatla, I. Kovanecz, M. Ferrini, N. F. Gonzalez-Cadavid, and J. Rajfer, “Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review,” International Journal of Impotence Research, vol. 20, no. 1, pp. 30–34, 2008. View at Publisher · View at Google Scholar · View at PubMed
  68. A. Müller, K. Kobylarz, and J. Mulhall, “Micro array analysis of the impact of sildenafil treatment on gene expression in the rat cavernous injury model,” European Urology Supplements, vol. 7, no. 3, p. 143, 2008, abstract 289. View at Publisher · View at Google Scholar
  69. A. Müller, R. Tal, J. F. Donohue et al., “The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model,” Journal of Sexual Medicine, vol. 5, no. 3, pp. 562–570, 2008. View at Publisher · View at Google Scholar · View at PubMed
  70. K. T. Chong, N. B. Hampson, D. G. Bostwick, R. L. Vessella, and J. M. Corman, “Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitis,” BJU International, vol. 94, no. 9, pp. 1275–1278, 2004. View at Publisher · View at Google Scholar · View at PubMed
  71. B. Kaminska, K. Gaweda-Walerych, and M. Zawadzka, “Molecular mechanisms of neuroprotective action of immunosuppressants—facts and hypotheses,” Journal of Cellular and Molecular Medicine, vol. 8, no. 1, pp. 45–58, 2004. View at Publisher · View at Google Scholar
  72. A. J. Bella, G. Lin, I. Cagiannos, and T. F. Lue, “Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury,” Asian Journal of Andrology, vol. 10, no. 1, pp. 54–59, 2008. View at Publisher · View at Google Scholar · View at PubMed
  73. B. G. Gold, K. Katoh, and T. Storm-Dickerson, “The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve,” Journal of Neuroscience, vol. 15, no. 11, pp. 7509–7516, 1995. View at Google Scholar
  74. M. Lee, V. B. Doolabh, S. E. Mackinnon, and S. Jost, “FK506 promotes functional recovery in crushed rat sciatic nerve,” Muscle & Nerve, vol. 23, no. 4, pp. 633–640, 2000. View at Google Scholar
  75. S. F. Sezen, A. Hoke, A. L. Burnett, and S. H. Snyder, “Immunophilin ligand FK506 is neuroprotective for penile innervation,” Nature Medicine, vol. 7, no. 10, pp. 1073–1074, 2001. View at Publisher · View at Google Scholar · View at PubMed
  76. A. L. Burnett and R. E. Becker, “Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury,” Journal of Urology, vol. 171, no. 1, pp. 495–500, 2004. View at Publisher · View at Google Scholar · View at PubMed
  77. G. Lagoda, L. Jin, T. J. Lehrfeld, T. Liu, and A. L. Burnett, “FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms,” Journal of Sexual Medicine, vol. 4, no. 4, part 1, pp. 908–916, 2007. View at Publisher · View at Google Scholar · View at PubMed
  78. R. Fleischmann, I. Iqbal, and R. L. Stern, “Tacrolimus in rheumatoid arthritis,” Expert Opinion on Pharmacotherapy, vol. 7, no. 1, pp. 91–98, 2006. View at Publisher · View at Google Scholar · View at PubMed
  79. H. Valentine, Y. Chen, H. Guo et al., “Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms,” European Urology, vol. 51, no. 6, pp. 1724–1731, 2007. View at Publisher · View at Google Scholar · View at PubMed
  80. A. L. Burnett, M. F. Kramer, S. Dalrymple, and J. T. Isaacs, “Nonimmunosuppressant immunophilin ligand GPI-1046 does not promote in vitro growth of prostate cancer cells,” Urology, vol. 65, no. 5, pp. 1003–1007, 2005. View at Publisher · View at Google Scholar · View at PubMed
  81. A. J. Bella, N. Hayashi, R. E. Carrion, R. Price, and T. F. Lue, “FK1706 enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat,” Journal of Sexual Medicine, vol. 4, no. 2, pp. 341–347, 2007. View at Publisher · View at Google Scholar · View at PubMed
  82. N. Hayashi, T. X. Minor, R. Carrion, R. Price, L. Nunes, and T. F. Lue, “The effect of FK1706 on erectile function following bilateral cavernous nerve crush injury in a rat model,” Journal of Urology, vol. 176, no. 2, pp. 824–829, 2006. View at Publisher · View at Google Scholar · View at PubMed
  83. K.-C. Chen, T. X. Minor, N. U. Rahman, H.-C. Ho, L. Nunes, and T. F. Lue, “The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence,” BJU International, vol. 95, no. 7, pp. 1077–1080, 2005. View at Publisher · View at Google Scholar · View at PubMed
  84. A. Laurikainen, J. O. Hiltunen, J. Thomas-Crusells et al., “Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat,” Journal of Neurobiology, vol. 43, no. 2, pp. 198–205, 2000. View at Google Scholar
  85. M. L. Leitner, D. C. Molliver, P. A. Osborne et al., “Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRα coreceptor-specific,” Journal of Neuroscience, vol. 19, no. 21, pp. 9322–9331, 1999. View at Google Scholar
  86. A. J. Bella, T. M. Fandel, K. Tantiwongse et al., “Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat,” Journal of Brachial Plexus and Peripheral Nerve Injury, vol. 2, no. 1, article 5, pp. 1–6, 2007. View at Publisher · View at Google Scholar · View at PubMed
  87. T. M. Fandel, A. J. Bella, K. Tantiwongse et al., “The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury,” BJU International, vol. 98, no. 3, pp. 632–636, 2006. View at Publisher · View at Google Scholar · View at PubMed
  88. W. M. Campana and R. R. Myers, “Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury,” The FASEB Journal, vol. 15, no. 10, pp. 1804–1806, 2001. View at Google Scholar
  89. X. Li, S. L. Gonias, and W. M. Campana, “Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury,” Glia, vol. 51, no. 4, pp. 254–265, 2005. View at Publisher · View at Google Scholar · View at PubMed
  90. M. E. Allaf, A. Hoke, and A. L. Burnett, “Erythropoetin promotes the recovery of erectile function following cavernous nerve injury,” Journal of Urology, vol. 174, no. 5, pp. 2060–2064, 2005. View at Publisher · View at Google Scholar · View at PubMed
  91. T. Liu, M. E. Allaf, G. Lagoda, and A. L. Burnett, “Erythropoetin receptor expression in the human urogenital tract: immunolocalization in the prostate, neurovascular bundle, and penis,” BJU International, vol. 100, no. 5, pp. 1103–1106, 2007. View at Publisher · View at Google Scholar · View at PubMed
  92. Y. S. Song, H. J. Lee, I. H. Park, W. K. Kim, J. H. Ku, and S. U. Kim, “Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells,” International Journal of Impotence Research, vol. 19, no. 4, pp. 378–385, 2007. View at Publisher · View at Google Scholar · View at PubMed
  93. Y. S. Song, H. J. Lee, I. H. Park, I. S. Lim, J. H. Ku, and S. U. Kim, “Human neural crest stem cells transplanted in rat penile corpus cavernosum to repair erectile dysfunction,” BJU International. In press. View at Publisher · View at Google Scholar · View at PubMed
  94. D. Bochinski, G. T. Lin, L. Nunes et al., “The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury,” BJU International, vol. 94, no. 6, pp. 904–909, 2004. View at Publisher · View at Google Scholar · View at PubMed
  95. A. J. Bella, M. M. Garcia, G. Lin, T. M. Fandel, W. O. Brant, and T. F. Lue, “Adult adipose tissue derived stem cells enhance neurite outgrowth from the major pelvic ganglion in the rat,” Canadian Urological Association Journal, vol. 1, p. 200, 2007, abstract 2.01. View at Google Scholar